THE RISK OF TRANSFORMATION OF FOLLICULAR LYMPHOMA "TRANSFORMED" BY RITUXIMAB: THE ARISTOTLE STUDY PROMOTED BY THE EUROPEAN LYMPHOMA INSTITUTE. (June 2017)

• Record Type: Journal Article
• Authors: Federico, M.; Caballero, D.; Marcheselli, L.; Tarantino, V.; Sarkozy, C.; Lopez Guillermo, A.; Wondergem, M.; Kimby, E.; Rusconi, C.; Zucca, E.; Montoto, S.; da Silva, M.G.; Aurer, I.; Paszkiewicz‐Kozik, E.; Cartron, G.; Morschhauser, F.; Alcoceba, M.; Chamuleau, M.; Lockmer, S.; Minoia, C.; Issa, D.; Alonso, S.; Conte, L.; Salles, G.; Coiffier, B.
• Is Part Of: Hematological oncology. Volume 35(2017)Supplement 2
• Page Start: 115
• Page End: 116
• Publication Date: 2017-06
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.2437_104
• Languages: English
• ISSNs: 0278-0232